Growth Metrics

Bio-Rad Laboratories (BIO) Total Non-Current Liabilities (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 11.7% to $2.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Dec 2025, up 11.7% year-over-year, with the annual reading at $2.9 billion for FY2025, 11.7% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $2.9 billion at Bio-Rad Laboratories, up from $2.8 billion in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $4.4 billion in Q3 2021, with the low at $2.6 billion in Q4 2024.
  • Average Total Non-Current Liabilities over 5 years is $3.3 billion, with a median of $3.3 billion recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities soared 46.22% in 2021, then dropped 22.85% in 2022.
  • Over 5 years, Total Non-Current Liabilities stood at $3.9 billion in 2021, then dropped by 6.14% to $3.7 billion in 2022, then fell by 8.88% to $3.4 billion in 2023, then fell by 22.16% to $2.6 billion in 2024, then increased by 11.7% to $2.9 billion in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $2.9 billion, $2.8 billion, and $2.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.